Last quarter (Q3 2023), XORTX Therapeutics Inc's total revenue was C$―, a decrease of ― from the same quarter last year. In Q3, XORTX Therapeutics Inc's net income was C$-1.33M. See XORTX Therapeutics Inc’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	-	-	-	C$ 0.00	C$ 0.00	C$ 0.00
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Expense	C$ 1.51M	C$ 13.39M	C$ 3.65M	C$ 1.30M	C$ 565.97K	C$ 1.16M
Operating Income	C$ -8.43M	C$ -13.39M	C$ -3.65M	C$ -1.30M	C$ -565.97K	C$ -1.16M
Net Non Operating Interest Income Expense	C$ 276.65K	C$ 137.57K	C$ 5.60K	C$ -13.51K	C$ -37.21K	C$ -22.30K
Other Income Expense	C$ 825.04K	C$ -3.21M	C$ 2.00M	C$ 29.41K	C$ -26.40K	C$ -2.60M
Pretax Income	C$ -7.78M	C$ -9.49M	C$ -1.65M	C$ -1.28M	C$ -629.58K	C$ -3.78M
Tax Provision	-	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	C$ -7.78M	C$ -9.49M	C$ -1.65M	C$ -1.28M	C$ -629.58K	C$ -3.78M
Basic EPS	C$ -1.08	C$ -0.71	C$ -0.17	C$ -0.19	C$ -0.01	C$ -0.06
Diluted EPS	C$ -1.08	C$ -0.71	C$ -0.17	C$ -0.19	C$ -0.01	C$ -0.06
Basic Average Shares	C$ 50.67M	C$ 13.32M	C$ 9.85M	C$ 6.66M	C$ 62.92M	C$ 61.82M
Diluted Average Shares	C$ 50.67M	C$ 13.32M	C$ 9.85M	C$ 6.66M	C$ 62.92M	C$ 61.82M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	C$ 1.51M	C$ 13.39M	C$ -3.65M	C$ 1.30M	C$ 565.97K	C$ 1.16M
Net Income From Continuing And Discontinued Operation	C$ -7.78M	C$ -9.49M	C$ -1.65M	C$ -1.28M	C$ -629.58K	C$ -3.78M
Normalized Income	C$ -6.49M	C$ -6.97M	C$ -1.21M	C$ -1.31M	C$ -603.18K	C$ -1.18M
Interest Expense	-	-	-	C$ 13.51K	C$ 37.21K	C$ 22.30K
EBIT	C$ -7.85M	C$ -9.49M	C$ -1.65M	C$ -1.27M	C$ -592.36K	C$ -3.75M
EBITDA	C$ -4.74M	C$ -9.41M	C$ -1.63M	C$ -1.25M	C$ -572.46K	C$ -3.73M

Currency in CAD

XORTX Therapeutics Inc Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing